The Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion.

Recruiting Observational Study
Cardiovascular Diseases Arrhythmia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
210 (estimated)
Sponsor
Affiliated Hospital of Nantong University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Objective: To evaluate the safety and efficacy of transcatheter atrial fibrillation ablation 1 month after WATCHMAN FLX left atrial appendage closure in patients with nonvalvular atrial fibrillation.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. ≥18 years of age, diagnosed with nonvalvular atrial fibrillation; 2. Meet the indications for receiving WATCHMAN FLX left atrial appendicular closure and transcatheter atrial fibrillation ablation; 3. Preoperative imaging evaluation showed that the anatomical structure of the…
Contacts

Qi Lu MD

+8613962989292

luqint@sina.com

CONTACT

Jian Zhang MD

13776926152

CONTACT